Progressing the Development of AZD2811 Nanoparticle

preview_player
Показать описание
Dr. Marianne Ashford, PhD, Principal Scientist Drug Targeting, Pharmaceutical Development AstraZeneca, Macclesfield, Cheshire (UK)

13. Overcoming Barriers ‐ Pharmaceutical Development and Manufacturing
CLINAM 2018
11th European and Global Summit for Clinical
Nanomedicine, Targeted Delivery and Precision Medicine
Hall Montreal
4.9.18
  1. TAUVOD
  2. CLINAM 2018
Рекомендации по теме
Progressing the Development 0:16:07

Progressing the Development of AZD2811 Nanoparticle

Pharmaceutical Development of 0:13:09

Pharmaceutical Development of Nanomedicines – Initial Learnings & Challenges

Development of Nanoparticles 0:16:44

Development of Nanoparticles for Clinical use: Importance of Degradation and Excretion

Hagop Youssoufian - 1:03:56

Hagop Youssoufian - Developing Accurate Nanomedicines - The BIND Therapeutics Approach

CriPec® Nanomedicines the 0:15:42

CriPec® Nanomedicines the Translational Path from Preclinical to Clinical Studies

CART Manufacturing 0:10:23

CART Manufacturing

Opening Address from 0:02:45

Opening Address from the European Foundation for Clinical Nanomedicine

Rise of the 0:12:45

Rise of the Machines— Artificial Intelligence and Security

Panel: Education, Workforce 0:43:04

Panel: Education, Workforce and Regulatory Matters in Novel Nano and Precision Drugs

Exosomes: potential drug 0:11:13

Exosomes: potential drug delivery agents?